B
Bavarian Nordic
Biopharmaceutical company developing cancer immunotherapies and vaccines against infectious diseases
At a glance
- Founded
- 1994
- Headquarters
- Gentofte Municipality, Denmark
- Listing
- IPO 1998
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Bavarian Nordic.
Source: Dealroom Talent Intelligence.
Alumni founders
Former Bavarian Nordic employees who went on to found companies, sorted by Dealroom signal score.
MIMinervaxEst. 2010
AUAustrianovaEst. 2001
SBSlingshot BiosciencesEst. 2012
Anh-Tuan NguyenUnited States
RIRecon InstrumentsEst. 2008
Dan EisenhardtCanadaGlobal footprint
team presence
Patents
64 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bavarian Nordic on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bavarian Nordic on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.